# A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine

> **NCT01081795** · PHASE2 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 387 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01081795
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2013-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01081795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01081795, "A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01081795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*